Enhancement of DNA synthesis and cAMP content of mouse thymocytes by mediator(s) derived from adherent cells
- PMID: 178798
Enhancement of DNA synthesis and cAMP content of mouse thymocytes by mediator(s) derived from adherent cells
Abstract
Supernatants of adherent mouse peritoneal exudate cells or human mononuclear cells were used as the source of lymphocyte activation factor (LAF). LAF was found to potentiate the effect of mitogens such as PHA and Con A on DNA synthesis by mouse thymocytes. However, LAF also was capable of reducing vigorous thymosyte reactions to Con A. Thus, LAF usually enhanced the effect of PHA on DNA synthesis by BALB/c thymocytes to a relatively greater degree than that of Con A. This change in the ratio of Con A to PHA response of thymocytes suggests that LAF can serve as a regulator of thymocyte DNA synthesis. Moreover, in the presence of LAF, allogeneic thymocytes developed the ability to have bidirectional mixed thymocyte reactions. Exposure to LAF not only improved the ability of parental thymocytes to act as responder cells, but, in addition, led to increased stimulatory activity of F1 thymocytes, presumably by promoting the differentiation of stimulator cells. These indications that LAF affected differentiation were investigated further by studying its effect on the cAMP content of thymocytes. LAF stimulated significant immediate but transient elevations of intracellular cAMP and adenylate cyclase activity in thymocyte membranes. In contrast, the mitogens themselves failed to elevate or to influence the effect of LAF on the content of intracellular cAMP of thymocytes. Furthermore, the potentiating effect of LAF on mitogen-induced thymocyte DNA synthesis at times was enhanced by exogenous cGMP, carbachol, or imidazole. These findings suggest that LAF, through its stimulation of cAMP levels in thymocytes may in turn promote thymocytes to differentiate sufficiently to become competent to proliferative in response to mitogens.
Similar articles
-
Interaction between lymphocytes and inflammatory exudate cells. I. Enhacement of thymocyte response to PHA by product(s) of polymorphonuclear leukocytes and macrophages.J Immunol. 1975 Aug;115(2):533-8. J Immunol. 1975. PMID: 1080171
-
Two distinct lumphocyte-stimulating soluble factors (LAF) released from murine peritoneal cells. I. The cellular source and the effect of cGMP on their release.Immunology. 1976 May;30(5):741-7. Immunology. 1976. PMID: 179941 Free PMC article.
-
Thymocyte and macrophage interactions: separation of murine thymocyte subsets and enrichment of syngeneic cell-responding thymocytes by adsorption to macrophage monolayers.J Immunol. 1983 Nov;131(5):2110-6. J Immunol. 1983. PMID: 6226732
-
Enhancement of macrophage Fc-dependent phagocytosis by resident thymocytes: effect of a unique heat-stable lymphokine.J Immunol. 1983 May;130(5):2195-9. J Immunol. 1983. PMID: 6339624
-
Release of mitogenic factor by mouse lymph node cells stimulated with PHA in vitro. Inhibition of this phenomenon by the addition of thymocytes.J Immunol. 1975 May;114(5):1623-30. J Immunol. 1975. PMID: 1079041
Cited by
-
Effects of osteoclast activating factor from human lymphocytes on cyclic AMP concentrations in isolated mouse bone and bone cells.Calcif Tissue Int. 1979 Aug 24;28(1):23-32. doi: 10.1007/BF02441214. Calcif Tissue Int. 1979. PMID: 227549 No abstract available.
-
Impaired production and lack of secretion of interleukin 1 by human breast milk macrophages.Clin Exp Immunol. 1988 Mar;71(3):493-6. Clin Exp Immunol. 1988. PMID: 3260159 Free PMC article.
-
Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen.J Exp Med. 1979 Sep 19;150(3):709-14. doi: 10.1084/jem.150.3.709. J Exp Med. 1979. PMID: 314491 Free PMC article.
-
In-vivo blockage of neutrophil migration by LPS is mimicked by a factor released from LPS-stimulated macrophages.Br J Exp Pathol. 1989 Feb;70(1):1-8. Br J Exp Pathol. 1989. PMID: 2647118 Free PMC article.
-
Suppression of pulmonary granulomatous inflammation by immunomodulating agents.Agents Actions. 1992 Sep;37(1-2):99-106. doi: 10.1007/BF01987896. Agents Actions. 1992. PMID: 1456185
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources